MNK-6105

· Mallinckrodt

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNK-6105, covering 2021-09-22 to 2021-09-22. Get the full timeline:

Most recent: Clinical Trial Update: MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function [Phase 3]